PDSB
PDS Biotechnology Corporation - Common Stock (PDSB)
$57
About PDS Biotechnology Corporation - Common Stock (PDSB)
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Details
Daily high
$1.63
Daily low
$1.55
Price at open
$1.60
52 Week High
$4.42
52 Week Low
$0.85
Market cap
72.2M
Dividend yield
0.00%
Volume
1.3M
Avg. volume
325,998
P/E ratio
-1.68
PDS Biotechnology Corporation - Common Stock News
Details
Daily high
$1.63
Daily low
$1.55
Price at open
$1.60
52 Week High
$4.42
52 Week Low
$0.85
Market cap
72.2M
Dividend yield
0.00%
Volume
1.3M
Avg. volume
325,998
P/E ratio
-1.68